Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Looking for quick cash? Here are effective ways to make money in one day, helping you boost your income instantly.
24,865 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Casella Waste Systems has seen a notable share-price pullback. A new stake by 4D Advisors adds a layer of intrigue. T...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...
Craving AI gains but wary of pitfalls? This guide shows how to diversify portfolio 2026 by steering clear of two risk...
As bond markets evolve, a widely used bond ETF faces renewed scrutiny over cost and hedging power. Investors are aske...
As 2026 unfolds, investors are weighing two distinct construction niche stocks. This guide breaks down how Concrete P...
In 2026, investors face a choice between a reliable components maker and a bold energy storage innovator. This guide ...
A routine 2026 cash-out from a CD ladder could lift Medicare premiums in 2028 due to IRMAA lookback rules. Retirees s...
Three dividend ETFs stand out as 2026 nears: SCHD for cost and broad exposure, HDV for quality screening, and DGRO fo...
CoStar Group blends a high performing CRE data backbone with a slower moving homes marketplace. This piece breaks dow...
This guide unpacks Granite Ridge earnings in plain terms. Learn the key metrics, what to listen for in the GRNT earni...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...